Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
  1. S-3 Offering Registration Statement
  2. 8-K/A Event Exhibits
  3. 8-K Event Other events
  4. D Other Notice of Sales of Unregistered Securities
  5. SC 13D Stake Beneficial Ownership Report
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 2,409 shares at $41.51 ($99,998)
  8. SC 13G Stake Amended Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 8-K/A Event Exhibits
  18. 4 Grant or award 10% owner acquired 288,170 shares (grant or award)
  19. 4 Open-market buy 10% owner bought 230,536 shares
  20. 3 Insider Initial Statement of Ownership

Page 11 of 19 · 368 filings